Clinical Trials

NCT06671912 | SUSPENDED | PHASE3
1556 participants

Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2025-02-19
Completion:
2030-11-30
Conditions
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • Anatomic Stage 1 Breast Cancer AJCC v8
  • Anatomic Stage IIA Breast Cancer AJCC v8
  • Estrogen Receptor-Positive Breast Carcinoma
  • HER2-Negative Breast Carcinoma
  • Breast Ductal Carcinoma In Situ
  • Breast Lobular Carcinoma In Situ
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT06661720 | RECRUITING | PHASE3
1040 participants

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2025-03-14
Completion:
2037-11-30
Conditions
  • Clear Cell Renal Cell Carcinoma
  • Renal Cell Carcinoma (RCC)
  • Stage II Renal Pelvis Cancer AJCC v8
  • Stage III Renal Pelvis Cancer AJCC v8
Interventions
  • BIOLOGICAL
  • DRUG
  • PROCEDURE
  • OTHER
No Results Yet
NCT06618794 | ACTIVE_NOT_RECRUITING | NA
202 participants

Recovery Legal Care Clinical Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2025-02-10
Completion:
2027-06-30
Conditions
  • Firearm Injury
  • Economic Problems
  • Injury Traumatic
Interventions
  • OTHER
No Results Yet
NCT06608758 | RECRUITING
120000 participants

End Diagnostic Overshadowing

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-05
Start Date:
2024-11-22
Completion:
2029-03-31
Conditions
  • Disabilities Multiple
Interventions
  • BEHAVIORAL
  • OTHER
No Results Yet
NCT06589804 | RECRUITING | PHASE3
158 participants

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2025-03-27
Completion:
2029-11-30
Conditions
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Hypopharyngeal Squamous Cell Carcinoma
  • Metastatic Laryngeal Squamous Cell Carcinoma
  • Metastatic Oral Cavity Squamous Cell Carcinoma
  • Metastatic Oropharyngeal Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • Recurrent Laryngeal Squamous Cell Carcinoma
  • Recurrent Neck Squamous Cell Carcinoma of Unknown Primary
  • Recurrent Oral Cavity Squamous Cell Carcinoma
  • Recurrent Oropharyngeal Squamous Cell Carcinoma
  • Refractory Head and Neck Squamous Cell Carcinoma
  • Refractory Hypopharyngeal Squamous Cell Carcinoma
  • Refractory Laryngeal Squamous Cell Carcinoma
  • Refractory Oral Cavity Squamous Cell Carcinoma
  • Refractory Oropharyngeal Squamous Cell Carcinoma
  • Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
  • Stage IV Hypopharyngeal Carcinoma AJCC v8
  • Stage IV Laryngeal Cancer AJCC v8
  • Stage IV Lip and Oral Cavity Cancer AJCC v8
  • Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Interventions
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT06527391 | RECRUITING | PHASE2/PHASE3
300 participants

Choline and Iron Deficiency

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2025-08-11
Completion:
2027-09-21
Conditions
  • Pediatric Iron Deficiency
  • Anemia
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT06473961 | RECRUITING | PHASE1
20 participants

A Phase Ib Study of GC101 in NSCLC

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2024-10-14
Completion:
2027-01-01
Conditions
  • Non Small Cell Lung Cancer Metastatic
  • Non Small Cell Lung Cancer
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page